SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 87,900
+300 (0.34%)
Nov 13, 2026, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 6.88 trillion as of November 12, 2026. It is the 3,471st most valuable company in the world and the 81st biggest in South Korea. Its market cap has decreased by 31.22% in one year.
Market Cap
6.88T
Enterprise Value
6.55T
Revenue
861.34B
Global Rank
Country Rank
#81 South Korea
PE Ratio
17.17
ChartMarket Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 6.88T, a decrease of -30.79%. That is a compound annual growth rate of -5.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 6.88T | -29.45% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 12.35T |
| Samsung Epis Holdings | 8.54T |
| HLB Co., Ltd. | 3.91T |
| SK bioscience | 3.08T |
| LigaChem Biosciences | 2.33T |
| ABL Bio | 2.28T |
| Peptron | 2.26T |
| Hugel | 2.12T |